JW Asset Management, LLC (“JW Asset” or the “Investment Manager”), a Delaware limited
liability company, was founded in November 2003 and provides discretionary investment
management services to certain private funds as discussed below.
Jason Wild owns a 99% interest in JW Asset, with Tamar Katzburg Wild, his spouse, controlling
the remaining 1%. Mr. Wild is the managing member of the Investment Manager and is
responsible for all the securities selections on behalf of the Investment Manager.
Mr. Wild is the president and managing member of each of JW Asset and JW GP, LLC (“JW GP”
or the “General Partner”). JW Asset serves as the investment manager for JW Growth Fund,
LLC, JW Opportunities Fund, LLC, JW Opportunities Fund, Ltd, JW Opportunities Master Fund,
Ltd, JW Partners, LP, JW Select Investments, LP (each a “Fund” and collectively, the “Funds”).
JW Asset also provides investment management services to Insight Wellness Fund, LLC, which
is managed by an unaffiliated managing member (not JW GP) and, except as noted or as the
context otherwise requires, is also deemed a “Fund” for purposes of this brochure.
Mr. Wild is responsible for all of the Funds’ investment decisions on behalf of JW Asset.
Mr.
Wild has over 20 years of experience as a portfolio manager and a fund manager. Over the
course of his career he has focused on the healthcare industry including specialty
pharmaceuticals, generic drugs, and cannabis. He is the executive chairman of TerrAscend
Corp. (“TerrAscend”), he is also a member of the board of Vitruvias Therapeutics, Inc.
(“Vitruvias”) and Allumia, Inc. (“Allumia”). Prior to the launch of JW Partners, LP in 1998, Mr.
Wild was a practicing pharmacist. He graduated from Long Island University in 1996 with a
Bachelor of Science in Pharmacy.
Please see Item 8 herein for a brief discussion of JW Asset’s investment strategies (collectively,
the “Strategies”). The Strategies generally focus on healthcare, consumer and retail sectors
and are tailored to each specific Fund. Important information regarding an investment in a
Fund, including the specific investment strategies and policies, fees and expenses, risk factors
and other material terms, are set forth in each Fund’s Offering Documents.
As of December 31, 2023 JW Asset’s discretionary regulatory assets under management were
approximately $450 million.
March 2024 5